Latka logo

Biospiel Revenue (2024)

Biospiel generated an estimated $3.2M in annual revenue in 2024. Source: GetLatka estimate

Biospiel connects medical professionals, students, and researchers to collaborate on medical imaging.

Last updated

Biospiel Revenue

In 2024, Biospiel's revenue reached $3.2M. The company previously reported $2.4M in 2023. Since its launch in 2020, Biospiel has shown consistent revenue growth.

Biospiel Revenue GrowthReported revenue / ARR over time · latest figure estimated$0$750K$1.5M$2.3M$3M$3.8M20202021202220232024$0$263K$2.4M$3.2MSource: GetLatka.com
YearMilestoneSource
2024Biospiel Hit $3.2m revenue in October 2024Estimated
2023Biospiel Hit $2.4m revenue in December 2023Estimated
2021Biospiel Hit $263k revenue in April 2021Not recorded
2020Launched with $0 revenue

Founder / CEO

Biospiel Employees & Team Size

Biospiel employs approximately 14 people as of 2026, down from 23 in 2023.

Biospiel Team GrowthReported headcount over time051015202520202021202220232024001414Source: GetLatka.com
YearMilestoneSource
2024Reached 14 employees (October 2024)Not recorded
2023Reached 23 employees (December 2023)Not recorded
2022Reached 11 employees (December 2022)Not recorded
2021Reached 3 employees (December 2021)Not recorded
2021Reached 11 employees (April 2021)Not recorded

Frequently Asked Questions about Biospiel

What is Biospiel's revenue?

As of 2024, Biospiel generated an estimated $3.2M in annual revenue.

Who founded Biospiel?

Biospiel was founded by Shahnawaz Asif.

When was Biospiel founded?

Biospiel was founded in 2020.

Who is the CEO of Biospiel?

The CEO of Biospiel is Shahnawaz Asif.

How many employees does Biospiel have?

As of 2024, Biospiel had 14 employees.

Where is Biospiel headquartered?

Biospiel is headquartered in Sheffield, England, United Kingdom.

Compare Biospiel to the industry

Biospiel operates across multiple industries. Browse revenue, funding, and growth data for Biospiel in each sector below.

Data and Sources

All figures on this page are taken directly from interviews or are estimates from public sources and proprietary models. Not financial advice. Read full disclaimer.

Claim this profile